Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

Abstract Background Direct primary care provision of first-trimester medical abortion could potentially address inequitable abortion access in Canada. However, when Health Canada approved the combination medication Mifegymiso® (mifepristone 200 mg/misoprostol 800 mcg) for medical abortion in July 20...

Full description

Bibliographic Details
Main Authors: Courtney Devane, Regina M. Renner, Sarah Munro, Édith Guilbert, Sheila Dunn, Marie-Soleil Wagner, Wendy V. Norman
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Pilot and Feasibility Studies
Subjects:
Mifepristone
Canada
Abortion
Survey
Family planning
Family physician
Online Access:http://link.springer.com/article/10.1186/s40814-019-0520-8

Internet

http://link.springer.com/article/10.1186/s40814-019-0520-8

Similar Items